Christina Coughlin has an extensive background in the pharmaceutical and biotechnology industries, with experience in various leadership roles such as Chief Executive Officer, Chief Medical Officer, and Principal. With a strong educational foundation in Medicine and Mathematics/Biology, Christina has worked for companies like Avacta, CytoImmune Therapeutics, and Novartis, focusing on oncology research and development. Christina is known for their expertise in cancer immunotherapy and collaboration in transforming the field.
April 1, 2024 - present
January, 2024
March, 2022